GoingToMeet

Enquiries: enquiries@euroscicon.com
Chair: Dr Eleanor Berrie, Clinical BioManufacturing Facility, University of Oxford, UK
Description: As both genomic and post-genomic analyses of pathogens and disease has advanced the production of successful recombinant vaccines we now require the strategies to both * select appropriate molecules and *deliver these vaccines effectively to stimulate protective immune responses.
Both candidate discovery and the tools for delivering vaccines effectively will be explored and discussed at this one day event

This meeting has CPD accreditation